Clinical and sociodemographic characteristics of metabolic dysfunction-associated fatty liver subtypes in Malaysia.
We aimed to describe the sociodemographic and clinical characteristics of subtypes of metabolic dysfunction-associated fatty liver disease (MAFLD) in Malaysia. MAFLD subtypes may be used for risk stratification, and individualised treatment may be considered for different subtypes.
We aimed to describe the sociodemographic and clinical characteristics of subtypes of metabolic dysfunction-associated fatty liver disease (MAFLD) in Malaysia. MAFLD subtypes may be used for risk stratification, and individualised treatment may be considered for different subtypes.
What the study was
- Study design
- Cross-sectional study
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- Scientific reports
Why it surfaced
Relevant Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk study (promising preliminary signal) meets standard-priority threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.